The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
New aspects of natural-killer-cell surveillance and therapy of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
The biology of human natural killer-cell subsets
Cooper, M. A., Fehniger, T. A., & Caligiuri, M. A. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02060-9 · Cited by 2,975
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768 · cited 1×
“Nevertheless, studies with mouse and humanized mAbs have shown that they engage both activation (FcγRIII) and inhibitory (FcγRIIB) receptors on myeloid cells, rather than through NK cell”
BackgroundSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
Kägi, D., Ledermann, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K. J., Podack, E. R., Zinkernagel, R. M., & Hengartner, H. (1994) · Nature · doi:10.1038/369031a0 · Cited by 1,757
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset
Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.10.3146 · Cited by 1,449
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Ashkenazi, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc821 · Cited by 1,360
(2016) · Diagnostic Pathology: Hospital Autopsy · doi:10.1016/b978-0-323-37676-1.50073-x · Cited by 1,335
Cosman, D., Müllberg, J., Sutherland, C. L., Chin, W., Armitage, R., Fanslow, W., Kubin, M., & Chalupny, N. J. (2001) · Immunity · doi:10.1016/s1074-7613(01)00095-4 · Cited by 1,232
Recognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
Groh, V., Steinle, A., Bauer, S., & Spies, T. (1998) · Science · doi:10.1126/science.279.5357.1737 · Cited by 1,142
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Fernandez, N. C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M., Tursz, T., Maraskovsky, E., & Zitvogel, L. (1999) · Nature Medicine · doi:10.1038/7403 · Cited by 1,060
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells
Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G., & Trinchieri, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010938 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation
Ruggeri, L., Capanni, M., Casucci, M., Volpi, I., Tosti, A., Perruccio, K., Urbani, E., Negrin, R. S., Martelli, M. F., & Velardi, A. (1999) · Blood · doi:10.1182/blood.v94.1.333.413a31_333_339 · Cited by 994
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
Interleukin 15: biology and relevance to human disease
Fehniger, T. A., & Caligiuri, M. A. (2001) · Blood · doi:10.1182/blood.v97.1.14 · Cited by 976
Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H. (2000) · Nature Immunology · doi:10.1038/77793 · Cited by 878
Natural killer cells, viruses and cancer
Cerwenka, A., & Lanier, L. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095564 · Cited by 875
Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis
Moore, R. J., Owens, D. M., Stamp, G., Arnott, C., Burke, F., East, N., Holdsworth, H., Turner, L., Rollins, B., Pasparakis, M., et al. (1999) · Nature Medicine · doi:10.1038/10552 · Cited by 839
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829
Self-citationTakeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., & Okumura, K. (2001) · Nature Medicine · doi:10.1038/83416 · Cited by 775
Self-citationInterleukin-12: A Cytokine at the Interface of Inflammation and Immunity
Trinchieri, G. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60387-9 · Cited by 760
Vitale, M., Bottino, C., Sivori, S., Sanseverino, L., Castriconi, R., Marcenaro, E., Augugliaro, R., Moretta, L., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2065 · Cited by 748
The unconventional lifestyle of NKT cells
Kronenberg, M., & Gapin, L. (2002) · Nature Reviews Immunology · doi:10.1038/nri854 · Cited by 747
Ljunggren, H. G., & Kärre, K. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.1745 · Cited by 736
Gong, J.-H., Maki, G., & Klingemann, H.-G. (1994) · PubMed · Cited by 723
Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells
Piccioli, D., Sbrana, S., Melandri, E., & Valiante, N. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010934 · Cited by 701
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
Rosenberg, S. A., Lotze, M. T., Yang, J. C., Topalian, S. L., Chang, A. E., Schwartzentruber, D. J., Aebersold, P., Leitman, S., Linehan, W. M., Seipp, C. A., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.8.622 · Cited by 639
Cretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1356 · Cited by 616
Self-citationCerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576
Self-citationPerforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Self-citationp46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Campbell, J. J., Qin, S., Unutmaz, D., Soler, D., Murphy, K. E., Hodge, M. R., Wu, L., & Butcher, E. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.11.6477 · Cited by 517
Decreased tumor surveillance in perforin-deficient mice.
van den Broek, M. E., Kägi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., Melief, C. J., Zinkernagel, R. M., & Hengartner, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1781 · Cited by 512
Smyth, M. J., Cretney, E., Takeda, K., Wiltrout, R. H., Sedger, L. M., Kayagaki, N., Yagita, H., & Okumura, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.661 · Cited by 512
Self-citationCostello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Reviron, D., Gastaut, J.-A., Pende, D., Olive, D., & Moretta, A. (2002) · Blood · doi:10.1182/blood.v99.10.3661 · Cited by 500
MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D. (1991) · Science · doi:10.1126/science.1853205 · Cited by 490
IL-21 Limits NK Cell Responses and Promotes Antigen-Specific T Cell Activation
Kasaian, M. T., Whitters, M. J., Carter, L. L., Lowe, L. D., Jussif, J. M., Deng, B., Johnson, K. A., Witek, J. S., Senices, M., Konz, R. F., et al. (2002) · Immunity · doi:10.1016/s1074-7613(02)00295-9 · Cited by 481
Takeda, K., Smyth, M. J., Cretney, E., Hayakawa, Y., Kayagaki, N., Yagita, H., & Okumura, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011171 · Cited by 465
Self-citationCaligiuri, M. A., Zmuidzinas, A., Manley, T. J., Levine, H., Smith, K. A., & Ritz, J. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1509 · Cited by 435
Waldmann, T. (2001) · Immunity · doi:10.1016/s1074-7613(09)00091-0 · Cited by 434
Activation and function of natural killer cell responses during viral infections
Biron, C. A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80155-0 · Cited by 420
Smyth, M. J., Crowe, N. Y., Pellicci, D. G., Kyparissoudis, K., Kelly, J. M., Takeda, K., Yagita, H., & Godfrey, D. I. (2002) · Blood · doi:10.1182/blood.v99.4.1259 · Cited by 392
Self-citationNK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379
Self-citationNK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
Self-citationSuppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
Street, S. E. A., Trapani, J. A., MacGregor, D., & Smyth, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020063 · Cited by 375
Self-citationEvaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
Davies, S. M., Ruggieri, L., DeFor, T., Wagner, J. E., Weisdorf, D. J., Miller, J. S., Velardi, A., & Blazar, B. R. (2002) · Blood · doi:10.1182/blood-2002-04-1197 · Cited by 368
Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection
Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., & Smyth, M. J. (2002) · Nature Immunology · doi:10.1038/ni746 · Cited by 356
Self-citationNatural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C., & Moretta, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01596-6 · Cited by 354
On guard—activating NK cell receptors
Lanier, L. L. (2001) · Nature Immunology · doi:10.1038/83130 · Cited by 346
Expression and Function of TNF-Related Apoptosis-Inducing Ligand on Murine Activated NK Cells
Kayagaki, N., Yamaguchi, N., Nakayama, M., Takeda, K., Akiba, H., Tsutsui, H., Okamura, H., Nakanishi, K., Okumura, K., & Yagita, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1906 · Cited by 340
Self-citationPende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
Nishimura, M., Umehara, H., Nakayama, T., Yoneda, O., Hieshima, K., Kakizaki, M., Dohmae, N., Yoshie, O., & Imai, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6173 · Cited by 326
Flt3 ligand induces tumor regression and antitumor immune responses in vivo
Lynch, D. H., Andreasen, A., Maraskovsky, E., Whitmore, J., Miller, R. E., & Schuh, J. C. L. (1997) · Nature Medicine · doi:10.1038/nm0697-625 · Cited by 308
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent
Smyth, M. J., Taniguchi, M., & Street, S. E. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2665 · Cited by 301
Self-citationPerforin Is a Major Contributor to NK Cell Control of Tumor Metastasis
Smyth, M. J., Thia, K. Y. T., Cretney, E., Kelly, J. M., Snook, M. B., Forbes, C. A., & Scalzo, A. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6658 · Cited by 295
Self-citationSignal Transduction during Natural Killer Cell Activation: Inside the Mind of a Killer
Leibson, P. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80441-0 · Cited by 292
Expression and regulation of chemokine receptors in human natural killer cells
Inngjerdingen, M., Damaj, B., & Maghazachi, A. A. (2001) · Blood · doi:10.1182/blood.v97.2.367 · Cited by 290
Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · PubMed · Cited by 277
Wiltrout, R. H., Herberman, R. B., Zhang, S. R., Chirigos, M. A., Ortaldo, J. R., Green, K. M., & Talmadge, J. E. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.6.4267 · Cited by 272
Cellular Immunotherapy of Malignancies Using the Clonal Natural Killer Cell Line NK-92
Tonn, T., Becker, S., Esser, R., Schwabe, D., & Seifried, E. (2001) · Journal of Hematotherapy & Stem Cell Research · doi:10.1089/15258160152509145 · Cited by 267
Tangye, S. G., Phillips, J. H., Lanier, L. L., & Nichols, K. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.2932 · Cited by 265
Le Dréan, E., Vély, F., Olcese, L., Cambiaggi, A., Guia, S., Krystal, G., Gervois, N., Moretta, A., Jotereau, F., & Vivier, E. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<264::aid-immu264>3.0.co;2-o · Cited by 254
Cutting Edge: Ly-49D and Ly-49H Associate with Mouse DAP12 and Form Activating Receptors
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.7 · Cited by 249
The Molecular and Functional Characterization of a Dominant Minor H Antigen, H60
Malarkannan, S., Shih, P. P., Eden, P. A., Horng, T., Zuberi, A. R., Christianson, G., Roopenian, D., & Shastri, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3501 · Cited by 233
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng, L. M., Ojcius, D. M., Garaud, F., Roth, C., Maxwell, E., Li, Z., Rong, H., Chen, J., Wang, X. Y., Catino, J. J., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.579 · Cited by 230
CD94-NKG2A receptors regulate antiviral CD8+ T cell responses
Moser, J. M., Gibbs, J., Jensen, P. E., & Lukacher, A. E. (2002) · Nature Immunology · doi:10.1038/ni757 · Cited by 220
Hayakawa, Y., Takeda, K., Yagita∥, H., Smyth, M. J., Kaer, L. V., Okumura, K., & Saiki, I. (2002) · PubMed · Cited by 219
Self-citationNatural killer cell activation in mice and men: different triggers for similar weapons?
Colucci, F., Di Santo, J. P., & Leibson, P. J. (2002) · Nature Immunology · doi:10.1038/ni0902-807 · Cited by 207
Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12
Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., & Tosato, G. (1999) · Blood · doi:10.1182/blood.v93.5.1612 · Cited by 201
A Central Role for Death Receptor-Mediated Apoptosis in the Rejection of Tumors by NK Cells
Screpanti, V., Wallin, R. P. A., Ljunggren, H.-G., & Grandien, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2068 · Cited by 201
Sivori, S., Falco, M., Marcenaro, E., Parolini, S., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072065999 · Cited by 195
Hayes, R. L., Koslow, M., Hiesiger, E. M., Hymes, K. B., Moore, E. J., Pierz, D. M., Hochster, H. S., Chen, D. K., Budzilovich, G. N., & Ransohoff, J. (1995) · Cancer · doi:10.1002/1097-0142(19950901)76:5<840::aid-cncr2820760519>3.0.co;2-r · Cited by 194
Fractalkine-Mediated Endothelial Cell Injury by NK Cells
Yoneda, O., Imai, T., Goda, S., Inoue, H., Yamauchi, A., Okazaki, T., Imai, H., Yoshie, O., Bloom, E. T., Domae, N., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4055 · Cited by 192
In vivo natural reactivity of mice against tumor cells
Riccardi, C., Santoni, A., Barlozzari, T., Puccetti, P., & Herberman, R. B. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910250409 · Cited by 176
Carson, W. E., Parihar, R., Lindemann, M. J., Personeni, N., Dierksheide, J. E., Meropol, N. J., Baselga, J. M., & Caligiuri, M. A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<3016::aid-immu3016>3.0.co;2-j · Cited by 175
Role of human natural killer cells in health and disease
Whiteside, T. L., & Herberman, R. B. (1994) · Clinical Diagnostic Laboratory Immunology · doi:10.1128/cdli.1.2.125-133.1994 · Cited by 173
Expression of Stress-induced MHC Class I Related Chain Molecules on Human Melanoma
Vetter, C. S., Groh, V., Straten, P. T., Spies, T., Bröcker, E.-B., & Becker, J. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01700.x · Cited by 171
Perforin dependence of natural killer cell‐mediated tumor control in vivo
van den Broek, M. F., Kägi, D., Zinkernagel, R. M., & Hengartner, H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251246 · Cited by 171
The Ly‐49 family: genes, proteins and recognition of class I MHC
Takei, F., Brennan, J., & Mager, D. L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00940.x · Cited by 168
Antileukemia activity of a natural killer cell line against human leukemias.
Yan, Y., Steinherz, P. G., Klingemann, H., Dennig, D., Childs, B. H., McGuirk, J. P., & O’Reilly, R. J. (1998) · PubMed · Cited by 167
Wiltrout, R. H., Mathieson, B. J., Talmadge, J. E., Reynolds, C. W., Zhang, S. R., Herberman, R. B., & Ortaldo, J. R. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1431 · Cited by 166
Barlozzari, T., Reynolds, C. W., & Herberman, R. B. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.2.1024 · Cited by 166
The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
Koo, G. C., Dumont, F. J., Tutt, M. M., et al. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.12.3742 · Cited by 162
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
Koh, C. Y., Blazar, B. R., George, T., Welniak, L. A., Capitini, C. M., Raziuddin, A., Murphy, W. J., & Bennett, M. (2001) · Blood · doi:10.1182/blood.v97.10.3132 · Cited by 160
Tomasello, E., Desmoulins, P.-O., Chemin, K., Guia, S., Cremer, H., Ortaldo, J., Love, P., Kaiserlian, D., & Vivier, E. (2000) · Immunity · doi:10.1016/s1074-7613(00)00035-2 · Cited by 159
Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
Kodama, T., Takeda, K., Shimozato, O., Hayakawa, Y., Atsuta, M., Kobayashi, K., Ito, M., Yagita∥, H., & Okumura, K. (1999) · European Journal of Immunology · Cited by 155
Self-citationSmyth, M. J., Kelly, J. M., Baxter, A. G., Körner, H., & Sedgwick, J. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1611 · Cited by 148
Self-citationLong, E. O., Barber, D. F., Burshtyn, D. N., Faure, M., Peterson, M., Rajagopalan, S., Renard, V., Sandusky, M., Stebbins, C. C., Wagtmann, N. R., et al. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810119.x · Cited by 146
Glas, R., Franksson, L., Une, C., Eloranta, M., Öhlén, C., Örn, A., & Kärre, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.129 · Cited by 146
Natural Killer Cells and Tumor Therapy
Whiteside, T. L., Vujanović, N. L., & Herberman, R. B. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-46859-9_13 · Cited by 141
Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo
Trapani, J. A., Davis, J. E., Sutton, V. R., & Smyth, M. J. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00094-7 · Cited by 138
Self-citationCD27-Mediated Activation of Murine NK Cells
Takeda, K., Oshima, H., Hayakawa, Y., Akiba, H., Atsuta, M., Kobata, T., Kobayashi, K., Ito, M., Yagita∥, H., & Okumura, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1741 · Cited by 131
Self-citationDirect in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12.
Duda, D. G., Sunamura, M., Lozonschi, L., Kodama, T., Egawa, S., Matsumoto, G., Shimamura, H., Shibuya, K., Takeda, K., & Matsuno, S. (2000) · PubMed · Cited by 127
Self-citationFogler, W. E., Völker, K., McCormick, K. L., Watanabe, M., Ortaldo, J. R., & Wiltrout, R. H. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4707 · Cited by 119
Loza, M. J., Zamai, L., Azzoni, L., Rosati, E., & PERUSSIA, B. (2002) · Blood · doi:10.1182/blood.v99.4.1273 · Cited by 115
Interleukin-2 in the treatment of renal cancer.
Margolin, K. A. (2000) · PubMed · Cited by 109
NK Cell Triggering by the Human Costimulatory Molecules CD80 and CD86
Wilson, J. L., Charo, J., Martin‐Fontecha, A., Dellabona, P., Casorati, G., Chambers, B. J., Kiessling, R. W., Bejarano, M.-T., & Ljunggren, H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4207 · Cited by 103
Bradley, M., Zeytun, A., Rafi-Janajreh, A., Nagarkatti, P. S., & Nagarkatti, M. (1998) · Blood · doi:10.1182/blood.v92.11.4248 · Cited by 99
Talmadge, J. E., Phillips, H., Schindler, J. D., et al. (1987) · PubMed · Cited by 94
Nakajima, A., Kodama, T., Morimoto, S., Azuma, M., Takeda, K., Oshima, H., Yoshino, S., Yagita∥, H., & Okumura, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1901 · Cited by 90
Self-citationCellular therapy: exploiting NK cell alloreactivity in transplantation
Ruggeri, L., Capanni, M., Martelli, M. F., & Velardi, A. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200111000-00007 · Cited by 87
Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12
Takeda, K., Hayakawa, Y., Atsuta, M., Hong, S., Kaer, L. V., Kobayashi, K., Ito, M., Yagita∥, H., & Okumura, K. (2000) · International Immunology · doi:10.1093/intimm/12.6.909 · Cited by 86
Self-citationGalea‐Lauri, J., Darling, D. C., Gan, S. U., Krivochtchapov, L., Kuiper, M., Gäken, J. A., Souberbielle, B. E., & Farzaneh, F. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.62 · Cited by 85
Gaspari, A. A., Fleisher, T. A., & Kraemer, K. H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116682 · Cited by 81
Cifone, M. G., D’Alò, S., Parroni, R., Millimaggi, D., Biordi, L. A., Martinotti, S., & Santoni, A. (1999) · Blood · doi:10.1182/blood.v93.11.3876 · Cited by 64
Kelly, J. M., Takeda, K., Darcy, P. K., Yagita∥, H., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4472 · Cited by 62
Self-citationFuruke, K., Burd, P. R., Horvath‐Arcidiacono, J. A., Hori, K., Mostowski, H. S., & Bloom, E. T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1473 · Cited by 60
Pawłowska, A., Hashino, S., McKenna, H. J., Weigel, B. J., Taylor, P. A., & Blazar, B. R. (2001) · Blood · doi:10.1182/blood.v97.5.1474 · Cited by 54
Spontaneous and induced primary oncogenesis in natural killer (nk)‐cell‐deficient beige mutant mice
Haliotis, T. P., Ball, J. K., Dexter, D. F., et al. (1985) · International Journal of Cancer · doi:10.1002/ijc.2910350414 · Cited by 54
Furuke, K., Burd, P. R., Horvath‐Arcidiacono, J. A., et al. (1999) · PubMed · Cited by 53
A family of murine NK cell receptors specific for target cell MHC class I molecules
Yokoyama, W. M., Daniels, B. F., Seaman, W. E., Hunziker, R., Margulies, D. H., & Smith, H. R. C. (1995) · Seminars in Immunology · doi:10.1006/smim.1995.0013 · Cited by 52
Kossman, S. E., Scheinberg, D. A., Jurcic, J. G., Jiménez, J. L., & Caron, P. C. (1999) · PubMed · Cited by 50
Impairment of Natural-Killer-Cell Activity in Xeroderma Pigmentosum
Norris, P. G., Limb, G. A., Hamblin, A. S., & Hawk, J. L. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812223192512 · Cited by 50
LaBelle, J. L., Hanke, C. A., Blazar, B. R., & Truitt, R. L. (2002) · Blood · doi:10.1182/blood.v99.6.2146 · Cited by 48
Brandau, S., Suttmann, H., Riemensberger, J., Seitzer, U., Arnold, J., Durek, C., Jocham, D., Flad, H. ‐., & Andreas Böhle, E. (2000) · PubMed · Cited by 47
Chang, E., & Rosenberg, S. A. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200101000-00010 · Cited by 45
Adoptive immunotherapy of advanced solid tumors: an eight year clinical experience.
Semino, C., Martini, L., Queirolo, P., Cangemi, G., Costa, R., Alloisio, A., Ferlazzo, G., Sertoli, M. R., Reali, U. M., Ratto, G. B., et al. (1999) · PubMed · Cited by 40
Maki, G., Krystal, G., Dougherty, G. J., et al. (1998) · Leukemia · doi:10.1038/sj.leu.2401145 · Cited by 27
Miyauchi‐Hashimoto, H., Okamoto, H., Horio, T., & Tanaka, K. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00597.x · Cited by 27
Renner, C., Hartmann, F., Jung, W. E., Deisting, C., Juwana, M., & Pfreundschuh, M. G. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050617 · Cited by 23
Immunodeficiency states and related malignancies
McClain, K. L. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-5767-8_2 · Cited by 22
Erianne, G. S., Wajchman, J., Yauch, R. L., Tsiagbe, V. K., Kim, B., & Ponzio, N. M. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00027-8 · Cited by 18
Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease
Costa, L. D., Renner, C., Hartmann, F., & Pfreundschuh, M. G. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/pl00014047 · Cited by 17
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Farhood, B., Najafi, M., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27782 · Cited by 1,658
NK cells and cancer: you can teach innate cells new tricks
Morvan, M. G., & Lanier, L. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.5 · Cited by 1,162
Satoh-Takayama, N., Vosshenrich, C. A. J., Lesjean-Pottier, S., Sawa, S., Lochner, M., Rattis, F., Mention, J.-J., Thiam, K., Cerf-Bensussan, N., Mandelboim, O., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.11.001 · Cited by 1,095
Metadata
- Authors
- Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H.
- Venue
- Nature Reviews Cancer
- Published
- 2002-11-01
- Volume
- 2
- Issue
- 11
- Pages
- 850-861
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2071742694
- Cited by
- 752
- References
- 137
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.